PMAM
ABBV icon

Picton Mahoney Asset Management’s AbbVie ABBV Stock Holding History

Picton Mahoney Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.42M Sell
25,497
-37,207
-59% -$8M 0.05% 325
2026
Q1 		$13.6M Sell
62,704
-7,527
-11% -$1.67M 0.1% 187
2025
Q4 		$16M Sell
70,231
-38,336
-35% -$8.73M 0.12% 141
2025
Q3 		$25.1M Buy
108,567
+31,753
+41% +$6.47M 0.23% 76
2025
Q2 		$14.3M Buy
76,814
+76,808
+1,280,133% +$14.3M 0.15% 137
2025
Q1 		$1K Hold
6
– – ﹤0.01% 693
2024
Q4 		$1K Hold
6
– – ﹤0.01% 592
2024
Q3 		$1K Buy
+6
New +$1.12K ﹤0.01% 583
2023
Q2 		– Sell
-53,717
Closed -$8.56M – 437
2023
Q1 		$8.56M Sell
53,717
-10,799
-17% -$1.65M 0.38% 87
2022
Q4 		$10.4M Sell
64,516
-3,189
-5% -$489K 0.49% 50
2022
Q3 		$9.09M Buy
67,705
+675
+1% +$96.9K 0.33% 56
2022
Q2 		$10.3M Buy
67,030
+46,865
+232% +$7.16M 0.39% 48
2022
Q1 		$3.27M Buy
+20,165
New +$2.93M 0.12% 227
2018
Q2 		– Sell
-209,600
Closed -$19.8M – 184
2018
Q1 		$19.8M Buy
209,600
+78,300
+60% +$8.6M 1.43% 18
2017
Q4 		$12.7M Buy
+131,300
New +$12.4M 0.91% 44
2015
Q1 		– Sell
-274,900
Closed -$18M – 285
2014
Q4 		$18M Sell
274,900
-14,200
-5% -$895K 0.86% 42
2014
Q3 		$16.7K Buy
289,100
+49,300
+21% +$2.74M 0.9% 40
2014
Q2 		$13.5K Sell
239,800
-271,200
-53% -$14.2M 0.79% 44
2014
Q1 		$26.3M Buy
511,000
+180,200
+54% +$9.11M 1.52% 11
2013
Q4 		$17.5M Sell
330,800
-15,600
-5% -$767K 1.02% 23
2013
Q3 		$15.5M Sell
346,400
-90,900
-21% -$4.03M 1.02% 26
2013
Q2 		$18.1M Buy
+437,300
New +$19.1M 1.34% 15

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Picton Mahoney Asset Management's ABBV Position: Q2 2026 in Review

Picton Mahoney Asset Management reduced its AbbVie (ABBV) stake by 59% in Q2 2026, selling an estimated $8M and leaving 25,497 shares worth $6.42M. The position accounts for 0.05% of the portfolio, ranked #325.

Picton Mahoney Asset Management first reported a position in ABBV in Q2 2013 and has held it in 22 quarters since. The position peaked at $26.3M in Q1 2014. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Picton Mahoney Asset Management held 25,497 shares of AbbVie worth $6.42M as of Q2 2026.
  • Picton Mahoney Asset Management sold 37,207 AbbVie shares in Q2 2026, an estimated $8M.
  • AbbVie made up 0.05% of Picton Mahoney Asset Management's portfolio in Q2 2026, its #325 holding.
  • Picton Mahoney Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 22 quarters since.
  • Picton Mahoney Asset Management's AbbVie position peaked at $26.3M in Q1 2014.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.